Skip to main content
Top
Published in: BMC Infectious Diseases 1/2016

Open Access 01-12-2015 | Research article

Clinical characteristics of the patients with bacteremia due to Moraxella catarrhalis in children: a case–control study

Authors: Takanori Funaki, Eisuke Inoue, Isao Miyairi

Published in: BMC Infectious Diseases | Issue 1/2016

Login to get access

Abstract

Background

Invasive diseases due to Moraxella catarrhalis are rare in children, even in immunocompromised hosts. Therefore, data regarding clinical characteristics and risk factors of such patients are limited. The aim of this study is to compare the clinical characteristics of patients with bacteremia due to Moraxella catarrhalis against those with bacteremia due to Streptococcus pneumoniae and Haemophilus influenzae.

Methods

We performed a retrospective case–control study to compare patients younger than 18 years of age with positive blood cultures for the three pathogens between June 2008 and May 2014 at our institution. Data regarding patients’ demographics and clinical course were collected from their medical records. Three group comparisons, with M. catarrhalis as reference, were made by the Fisher’s exact test and Wilcoxon rank sum test for discrete and continuous variables, respectively.

Results

There were eight cases of M. catarrhalis, 110 cases of S. pneumoniae (105 patients) and 22 cases of H. influenzae. The M. catarrhalis group consisted of six females (75 %) with a mean age of 16 months. The majority of patients (7/8, 88 %) had underlying diseases; however, only one was immunocompromised. Characteristically, six patients (75 %) had medical devices including trans-nasal devices (5/8, 63 %). Univariate analysis revealed that underlying conditions (P = 0.005), trans-nasal devices (P < 0.001), and lower body weight (P = 0.016) and low white blood cell count (P = 0.011) at the onset of illness were associated with the M. catarrhalis group compared to the S. pneumoniae group. Meanwhile, the higher rates of the patients with underlying conditions and trans-nasal devices were associated with the M. catarrhalis group compared to the H. influenzae group (P = 0.039, P < 0.001, respectively).

Conclusions

The presence of underlying conditions, particularly in those with trans-nasal devices, were characteristic features of patients with bacteremia due to M. catarrhalis.
Appendix
Available only for authorised users
Literature
1.
go back to reference Centers for Disease Control and Prevention (CDC). Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction--eight states, 1998–2005. MMWR Morb Mortal Wkly Rep. 2008;57(6):144–8. Centers for Disease Control and Prevention (CDC). Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction--eight states, 1998–2005. MMWR Morb Mortal Wkly Rep. 2008;57(6):144–8.
2.
go back to reference Centers for Disease Control and Prevention (CDC). Invasive pneumococcal disease in young children before licensure of 13-valent pneumococcal conjugate vaccine - United States, 2007. MMWR Morb Mortal Wkly Rep. 2010;59(9):253–7. Centers for Disease Control and Prevention (CDC). Invasive pneumococcal disease in young children before licensure of 13-valent pneumococcal conjugate vaccine - United States, 2007. MMWR Morb Mortal Wkly Rep. 2010;59(9):253–7.
3.
go back to reference Moore MR, Link-Gelles R, Schaffner W, Lynfield R, Lexau C, Bennett NM, et al. Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance. Lancet Infect Dis. 2015;15(3):301–9.CrossRefPubMed Moore MR, Link-Gelles R, Schaffner W, Lynfield R, Lexau C, Bennett NM, et al. Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance. Lancet Infect Dis. 2015;15(3):301–9.CrossRefPubMed
4.
go back to reference Centers for Disease Control and Prevention (CDC). Progress toward elimination of Haemophilus influenzae type b invasive disease among infants and children--United States, 1998–2000. MMWR Morb Mortal Wkly Rep. 2002;51(11):234–7. Centers for Disease Control and Prevention (CDC). Progress toward elimination of Haemophilus influenzae type b invasive disease among infants and children--United States, 1998–2000. MMWR Morb Mortal Wkly Rep. 2002;51(11):234–7.
5.
go back to reference Watt JP, Wolfson LJ, O’Brien KL, Henkle E, Deloria-Knoll M, McCall N, et al. Burden of disease caused by Haemophilus influenzae type b in children younger than 5 years: global estimates. Lancet. 2009;374(9693):903–11.CrossRefPubMed Watt JP, Wolfson LJ, O’Brien KL, Henkle E, Deloria-Knoll M, McCall N, et al. Burden of disease caused by Haemophilus influenzae type b in children younger than 5 years: global estimates. Lancet. 2009;374(9693):903–11.CrossRefPubMed
7.
go back to reference Murphy TF, Parameswaran GI. Moraxella catarrhalis, a human respiratory tract pathogen. Clin Infect Dis. 2009;49(1):124–31.CrossRefPubMed Murphy TF, Parameswaran GI. Moraxella catarrhalis, a human respiratory tract pathogen. Clin Infect Dis. 2009;49(1):124–31.CrossRefPubMed
8.
go back to reference Abuhammour WM, Abdel-Haq NM, Asmar BI, Dajani AS. Moraxella catarrhalis bacteremia: a 10-year experience. South Med J. 1999;92(11):1071–4.CrossRefPubMed Abuhammour WM, Abdel-Haq NM, Asmar BI, Dajani AS. Moraxella catarrhalis bacteremia: a 10-year experience. South Med J. 1999;92(11):1071–4.CrossRefPubMed
9.
go back to reference Baraff LJ, Oslund S, Prather M. Effect of antibiotic therapy and etiologic microorganism on the risk of bacterial meningitis in children with occult bacteremia. Pediatrics. 1993;92(1):140–3.PubMed Baraff LJ, Oslund S, Prather M. Effect of antibiotic therapy and etiologic microorganism on the risk of bacterial meningitis in children with occult bacteremia. Pediatrics. 1993;92(1):140–3.PubMed
10.
go back to reference American Academy of Pediatrics. Immunization in special clinical circumstances. In: Pickering LK, Baker CJ, Kimberlin DW, Long SS, editors. Red Book. 29th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2012. p. 69–109. American Academy of Pediatrics. Immunization in special clinical circumstances. In: Pickering LK, Baker CJ, Kimberlin DW, Long SS, editors. Red Book. 29th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2012. p. 69–109.
11.
go back to reference CLSI. Performance Standards for Antimicrobial Susceptibility Testing M100-S19; Nineteenth Informational Supplement, vol. 29. Wayne: Clinical and Laboratory Standards Institute; 2009. CLSI. Performance Standards for Antimicrobial Susceptibility Testing M100-S19; Nineteenth Informational Supplement, vol. 29. Wayne: Clinical and Laboratory Standards Institute; 2009.
12.
go back to reference Saitoh A, Okabe N. Current issues with the immunization program in Japan: can we fill the “vaccine gap”? Vaccine. 2012;30(32):4752–6.CrossRefPubMed Saitoh A, Okabe N. Current issues with the immunization program in Japan: can we fill the “vaccine gap”? Vaccine. 2012;30(32):4752–6.CrossRefPubMed
13.
go back to reference Saitoh A, Okabe N. Recent progress and concerns regarding the Japanese immunization program: addressing the “vaccine gap”. Vaccine. 2014;32(34):4253–8.CrossRefPubMed Saitoh A, Okabe N. Recent progress and concerns regarding the Japanese immunization program: addressing the “vaccine gap”. Vaccine. 2014;32(34):4253–8.CrossRefPubMed
15.
go back to reference R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: the R Foundation for statistical Computing; 2013. Available online at http://www.R-project.org/. R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: the R Foundation for statistical Computing; 2013. Available online at http://​www.​R-project.​org/​.
16.
go back to reference Del Beccaro MA, Mendelman PM, Inglis AF, et al. Bacteriology of acute otitis media: a new perspective. J Pediatr Jan. 1992;120(1):81–4.CrossRef Del Beccaro MA, Mendelman PM, Inglis AF, et al. Bacteriology of acute otitis media: a new perspective. J Pediatr Jan. 1992;120(1):81–4.CrossRef
17.
go back to reference Kilpi T, Herva E, Kaijalainen T, Syrjanen R, Takala AK. Bacteriology of acute otitis media in a cohort of Finnish children followed for the first two years of life. Pediatr Infect Dis J. 2001;20(7):654–62.CrossRefPubMed Kilpi T, Herva E, Kaijalainen T, Syrjanen R, Takala AK. Bacteriology of acute otitis media in a cohort of Finnish children followed for the first two years of life. Pediatr Infect Dis J. 2001;20(7):654–62.CrossRefPubMed
18.
go back to reference Ruohola A, Meurman O, Nikkari S, Skottman T, Salmi A, Waris M, et al. Microbiology of acute otitis media in children with tympanostomy tubes: prevalences of bacteria and viruses. Clin Infect Dis. 2006;43(11):1417–22.CrossRefPubMed Ruohola A, Meurman O, Nikkari S, Skottman T, Salmi A, Waris M, et al. Microbiology of acute otitis media in children with tympanostomy tubes: prevalences of bacteria and viruses. Clin Infect Dis. 2006;43(11):1417–22.CrossRefPubMed
19.
go back to reference Masuda K, Masuda R, Nishi J, Tokuda K, Yoshinaga M, Miyata K. Incidences of nasopharyngeal colonization of respiratory bacterial pathogens in Japanese children attending day-care centers. Pediatr Int. 2002;44(4):376–80.CrossRefPubMed Masuda K, Masuda R, Nishi J, Tokuda K, Yoshinaga M, Miyata K. Incidences of nasopharyngeal colonization of respiratory bacterial pathogens in Japanese children attending day-care centers. Pediatr Int. 2002;44(4):376–80.CrossRefPubMed
20.
go back to reference Block SL, Hedrick J, Harrison CJ, Tyler R, Smith A, Findlay R, et al. Community-wide vaccination with the heptavalent pneumococcal conjugate significantly alters the microbiology of acute otitis media. Pediat Infect Dis J. 2004;23(9):829–33.CrossRef Block SL, Hedrick J, Harrison CJ, Tyler R, Smith A, Findlay R, et al. Community-wide vaccination with the heptavalent pneumococcal conjugate significantly alters the microbiology of acute otitis media. Pediat Infect Dis J. 2004;23(9):829–33.CrossRef
21.
go back to reference Casey JR, Pichichero ME. Changes in frequency and pathogens causing acute otitis media in 1995–2003. Pediatr Infect Dis J. 2004;23(9):824–8.CrossRefPubMed Casey JR, Pichichero ME. Changes in frequency and pathogens causing acute otitis media in 1995–2003. Pediatr Infect Dis J. 2004;23(9):824–8.CrossRefPubMed
22.
go back to reference Brook I, Foote PA, Hausfeld JN. Frequency of recovery of pathogens causing acute maxillary sinusitis in adults before and after introduction of vaccination of children with the 7-valent pneumococcal vaccine. J Med Microbiol. 2006;55(Pt 7):943–6.CrossRefPubMed Brook I, Foote PA, Hausfeld JN. Frequency of recovery of pathogens causing acute maxillary sinusitis in adults before and after introduction of vaccination of children with the 7-valent pneumococcal vaccine. J Med Microbiol. 2006;55(Pt 7):943–6.CrossRefPubMed
23.
go back to reference Brook I, Gober AE. Frequency of recovery of pathogens from the nasopharynx of children with acute maxillary sinusitis before and after the introduction of vaccination with the 7-valent pneumococcal vaccine. Int J Pediatr Otorhinolaryngol. 2007;71(4):575–9.CrossRefPubMed Brook I, Gober AE. Frequency of recovery of pathogens from the nasopharynx of children with acute maxillary sinusitis before and after the introduction of vaccination with the 7-valent pneumococcal vaccine. Int J Pediatr Otorhinolaryngol. 2007;71(4):575–9.CrossRefPubMed
24.
go back to reference Ahmed A, Broides A, Givon-Lavi N, Peled N, Dagan R, Greenberg D. Clinical and laboratory aspects of Moraxella catarrhalis bacteremia in children. Pediatr Infect Dis J. 2008;27(5):459–61.CrossRefPubMed Ahmed A, Broides A, Givon-Lavi N, Peled N, Dagan R, Greenberg D. Clinical and laboratory aspects of Moraxella catarrhalis bacteremia in children. Pediatr Infect Dis J. 2008;27(5):459–61.CrossRefPubMed
25.
go back to reference McGregor K, Chang BJ, Mee BJ, Riley TV. Moraxella catarrhalis: clinical significance, antimicrobial susceptibility and BRO beta-lactamases. Eur J Clin Microbiol Infect Dis. 1998;17(4):219–34.CrossRefPubMed McGregor K, Chang BJ, Mee BJ, Riley TV. Moraxella catarrhalis: clinical significance, antimicrobial susceptibility and BRO beta-lactamases. Eur J Clin Microbiol Infect Dis. 1998;17(4):219–34.CrossRefPubMed
26.
go back to reference Meyer GA, Shope TR, Waecker Jr NJ, Lanningham FH. Moraxella (Branhamella) catarrhalis bacteremia in children. A report of two patients and review of the literature. Clin Pediatr. 1995;34(3):146–50.CrossRef Meyer GA, Shope TR, Waecker Jr NJ, Lanningham FH. Moraxella (Branhamella) catarrhalis bacteremia in children. A report of two patients and review of the literature. Clin Pediatr. 1995;34(3):146–50.CrossRef
27.
go back to reference Enright MC, McKenzie H. Moraxella (Branhamella) catarrhalis--clinical and molecular aspects of a rediscovered pathogen. J Med Microbiol. 1997;46(5):360–71.CrossRefPubMed Enright MC, McKenzie H. Moraxella (Branhamella) catarrhalis--clinical and molecular aspects of a rediscovered pathogen. J Med Microbiol. 1997;46(5):360–71.CrossRefPubMed
28.
go back to reference Ioannidis JP, Worthington M, Griffiths JK, Snydman DR. Spectrum and significance of bacteremia due to Moraxella catarrhalis. Clin Infect Dis. 1995;21(2):390–7.CrossRefPubMed Ioannidis JP, Worthington M, Griffiths JK, Snydman DR. Spectrum and significance of bacteremia due to Moraxella catarrhalis. Clin Infect Dis. 1995;21(2):390–7.CrossRefPubMed
29.
go back to reference Verduin CM, Hol C, Fleer A, van Dijk H, van Belkum A. Moraxella catarrhalis: from emerging to established pathogen. Clin Microbiol Rev. 2002;15(1):125–44.PubMedCentralCrossRefPubMed Verduin CM, Hol C, Fleer A, van Dijk H, van Belkum A. Moraxella catarrhalis: from emerging to established pathogen. Clin Microbiol Rev. 2002;15(1):125–44.PubMedCentralCrossRefPubMed
30.
go back to reference Bernstein JM, Reddy M. Bacteria-mucin interaction in the upper aerodigestive tract shows striking heterogeneity: implications in otitis media, rhinosinusitis, and pneumonia. Otolaryngol Head Neck Surg Apr. 2000;122(4):514–20. Bernstein JM, Reddy M. Bacteria-mucin interaction in the upper aerodigestive tract shows striking heterogeneity: implications in otitis media, rhinosinusitis, and pneumonia. Otolaryngol Head Neck Surg Apr. 2000;122(4):514–20.
31.
go back to reference Heiniger N, Spaniol V, Troller R, Vischer M, Aebi C. A Reservoir of Moraxella catarrhalis in Human Pharyngeal Lymphoid Tissue. J Infect Dis. 2007;196(7):1080–7.CrossRefPubMed Heiniger N, Spaniol V, Troller R, Vischer M, Aebi C. A Reservoir of Moraxella catarrhalis in Human Pharyngeal Lymphoid Tissue. J Infect Dis. 2007;196(7):1080–7.CrossRefPubMed
32.
go back to reference Cook PP, Hecht DW, Snydman DR. Nosocomial Branhamella catarrhalis in a paediatric intensive care unit: risk factors for disease. J Hosp Infect. 1989;13(3):299–307.CrossRefPubMed Cook PP, Hecht DW, Snydman DR. Nosocomial Branhamella catarrhalis in a paediatric intensive care unit: risk factors for disease. J Hosp Infect. 1989;13(3):299–307.CrossRefPubMed
33.
go back to reference Hager H, Verghese A, Alvarez S, Berk SL. Branhamella catarrhalis respiratory infections. Rev Infect Dis. 1987;9(6):1140–9.CrossRefPubMed Hager H, Verghese A, Alvarez S, Berk SL. Branhamella catarrhalis respiratory infections. Rev Infect Dis. 1987;9(6):1140–9.CrossRefPubMed
34.
go back to reference Luke NR, Jurcisek JA, Bakaletz LO, Campagnari AA. Contribution of Moraxella catarrhalis type IV pili to nasopharyngeal colonization and biofilm formation. Infect Immun. 2007;75(12):5559–64.PubMedCentralCrossRefPubMed Luke NR, Jurcisek JA, Bakaletz LO, Campagnari AA. Contribution of Moraxella catarrhalis type IV pili to nasopharyngeal colonization and biofilm formation. Infect Immun. 2007;75(12):5559–64.PubMedCentralCrossRefPubMed
Metadata
Title
Clinical characteristics of the patients with bacteremia due to Moraxella catarrhalis in children: a case–control study
Authors
Takanori Funaki
Eisuke Inoue
Isao Miyairi
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2016
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-016-1408-3

Other articles of this Issue 1/2016

BMC Infectious Diseases 1/2016 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.